SOLV vs. PODD, TFX, SWAV, GMED, PEN, GKOS, INSP, HAE, MMSI, and BAX
Should you be buying Solventum stock or one of its competitors? The main competitors of Solventum include Insulet (PODD), Teleflex (TFX), Shockwave Medical (SWAV), Globus Medical (GMED), Penumbra (PEN), Glaukos (GKOS), Inspire Medical Systems (INSP), Haemonetics (HAE), Merit Medical Systems (MMSI), and Baxter International (BAX). These companies are all part of the "surgical & medical instruments" industry.
Insulet (NASDAQ:PODD) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.
Insulet has a net margin of 13.14% compared to Insulet's net margin of 0.00%. Solventum's return on equity of 34.06% beat Insulet's return on equity.
Insulet received 712 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 66.05% of users gave Insulet an outperform vote while only 0.00% of users gave Solventum an outperform vote.
Insulet has higher revenue and earnings than Solventum.
In the previous week, Insulet had 20 more articles in the media than Solventum. MarketBeat recorded 24 mentions for Insulet and 4 mentions for Solventum. Insulet's average media sentiment score of 0.36 beat Solventum's score of 0.20 indicating that Solventum is being referred to more favorably in the news media.
Insulet currently has a consensus price target of $239.44, indicating a potential upside of 27.86%. Solventum has a consensus price target of $69.67, indicating a potential upside of 11.68%. Given Solventum's stronger consensus rating and higher probable upside, equities research analysts clearly believe Insulet is more favorable than Solventum.
Summary
Insulet beats Solventum on 10 of the 11 factors compared between the two stocks.
Get Solventum News Delivered to You Automatically
Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Solventum Competitors List
Related Companies and Tools
